The prevalence of eating disorders in females is about 8%, with 2% occurring in males as well (Galmiche et al., 2019). Eating disorders can be exceptionally difficult to diagnose due to a variety of factors, including but not limited to crossover between diagnoses. As such, many patients with anorexia nervosa end up with symptoms evolving to bulimia nervosa and vice versa, and there is significant crossover between patients with bulimia nervosa and binge eating disorder (Castellini et al., 2011). Eating disorders can also be obscured or confused with smptoms of medical illness (Devlin et al., 2011). Moreover, clinicians may be unfamiliar with atypical presentations within categories of eating disorders. For example, anorexia nervosa may be missed in an individual whose BMI is within the normal or greater than normal categories, for which a diagnosis of atypical anorexia nervosa can be provided (American Psychiatric Association, 2022). Lastly, treatment for eating disorders is primarily psychotherapeutic, and therefore, clinicians may be unaware of the pharmacology options that may be an important adjunct to treatment (Yager, 2022). Addressing both diagnostic challenges as well as treatment options is critical to expand practicing clinicians’ reach.